» Articles » PMID: 30449921

Bronchial Artery Embolization in Treatment of Hemoptysis: Treatment Efficacy and Complications at a Tertiary Care Chest Centre

Overview
Specialty General Medicine
Date 2018 Nov 20
PMID 30449921
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hemoptysis is one of the most alarming condition to both the patients suffering from it and the treating physicians. It is caused due to varied etiologies. One of the emergent and at times life-saving treatment option is by minimally invasive interventional radiological technique of Bronchial Atery Embolization (BAE). The authors aimed to carry out a retrospective analysis of short term efficacy and safety of all patients treated by this technique at a tertiary care thoracic centre.

Methods: A total of 52 patients were included in the study who had a median follow up of 35 days. All these patients were referred for hemoptysis, intractable hemoptysis not controlled by conservative management or massive hemoptysis. An analysis of the underlying etiology, immediate and short term outcomes and complications was made.

Results: The study showed Tuberculosis and its sequel (bronchiectasis and chronic fibrotic changes) as the commonest etiology (65%). The BAE showed high short term efficacy (92%) in stopping the hemoptysis with a relatively low complication rate especially of major complications such as spinal cord ischemia (1.9%). The study strengthens the limited Indian data available on the subject and based on its outcome, BAE should be tried in all patients presenting with uncontrollable or massive hemoptysis not getting relief by conservative management alone.

Conclusion: BAE is a very effective procedure with very less complications for management of massive or uncontrollable hemoptysis.

Citing Articles

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies.

Karlafti E, Tsavdaris D, Kotzakioulafi E, Kougias L, Tagarakis G, Kaiafa G J Pers Med. 2023; 13(12).

PMID: 38138876 PMC: 10744930. DOI: 10.3390/jpm13121649.


Massive Hemoptysis in Previously Treated Pulmonary Tuberculosis: A Case Series.

Iqbal S, Nassar M, Kondaveeti R, OBrien T, Siddiqui R, Lopez R Cureus. 2022; 14(8):e27882.

PMID: 36110488 PMC: 9463861. DOI: 10.7759/cureus.27882.


The Effectiveness of Gelfoam as the Sole and Primary Embolization Agent in the Management of Hemoptysis: A Retrospective Study from a Tertiary Care Center.

Ruge A, Kumar N, Menezes C J Clin Imaging Sci. 2021; 11:10.

PMID: 33767902 PMC: 7981937. DOI: 10.25259/JCIS_160_2020.

References
1.
FERRIS E . Pulmonary hemorrhage. Vascular evaluation and interventional therapy. Chest. 1981; 80(6):710-4. DOI: 10.1378/chest.80.6.710. View

2.
Walsh T, Anaissie E, Denning D, Herbrecht R, Kontoyiannis D, Marr K . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3):327-60. DOI: 10.1086/525258. View

3.
Poyanli A, Acunas B, Rozanes I, Guven K, Yilmaz S, Salmaslioglu A . Endovascular therapy in the management of moderate and massive haemoptysis. Br J Radiol. 2007; 80(953):331-6. DOI: 10.1259/bjr/34204483. View

4.
Ramakantan R, Bandekar V, Gandhi M, Aulakh B, Deshmukh H . Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology. 1996; 200(3):691-4. DOI: 10.1148/radiology.200.3.8756916. View

5.
Kato A, Kudo S, Matsumoto K, Fukahori T, Shimizu T, Uchino A . Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results. Cardiovasc Intervent Radiol. 2000; 23(5):351-7. DOI: 10.1007/s002700010062. View